Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
hepatocellular_carcinoma [2020/03/03 22:39]
admin [Related work]
hepatocellular_carcinoma [2020/03/18 20:45] (current)
admin [Related work]
Line 73: Line 73:
   - Subramaniam,​ Somasundaram,​ Robin K. Kelley, and Alan P. Venook. "A review of hepatocellular carcinoma (HCC) staging systems."​ [[http://​cco.amegroups.com/​article/​view/​2528/​3943|Chinese clinical oncology]] 2.4 (2013).​​​   - Subramaniam,​ Somasundaram,​ Robin K. Kelley, and Alan P. Venook. "A review of hepatocellular carcinoma (HCC) staging systems."​ [[http://​cco.amegroups.com/​article/​view/​2528/​3943|Chinese clinical oncology]] 2.4 (2013).​​​
   - Alexandrov, Ludmil B., et al. "The repertoire of mutational signatures in human cancer."​ [[https://​www.nature.com/​articles/​s41586-020-1943-3#​Sec17|Nature]] 578.7793 (2020): 94-101. \\  Analyzed WGS and WXS data of thousands of tumors available from TCGA and PCAWG consortia.   - Alexandrov, Ludmil B., et al. "The repertoire of mutational signatures in human cancer."​ [[https://​www.nature.com/​articles/​s41586-020-1943-3#​Sec17|Nature]] 578.7793 (2020): 94-101. \\  Analyzed WGS and WXS data of thousands of tumors available from TCGA and PCAWG consortia.
- +  ​Dr. Sukeshi Arora'​s {{:​sukeshi_arora_hcc_update_3.18.20.pptx|slides}} ​ presented in the HCC meeting on 2020-04-18, which summarizes statistics on the prognosis, the current clinical practice, and response to different treatments.
-----+